Letter to the Editor
Phenotypic variability of a likely FA2H founder mutation in a family with complicated hereditary spastic paraplegia
To the Editor:
Fatty acid hydroxylase-associated neurodegeneration (FAHN) is caused by mutations in FA2H (OMIM 612319) and encompasses a spectrum ranging from complicated spastic paraplegia (SPG35) (1, 2) , to leukodystrophy with spastic paraparesis and dystonia (3) , to neurodegeneration with brain iron accumulation (NBIA) (4, 5) . FA2H encodes fatty acid 2 hydroxylase, an important enzyme in galactolipid synthesis that is essential for neuronal myelin sheath maintenance. To date, only a few patients with FA2H mutations have been reported (1, 2, 4, 6, 7) .
We describe two siblings born to non-consanguineous parents from Montenegro with SPG35 caused by mutation in FA2H (Fig. 1a, b) . Patient 1 is a 13-year-old girl who developed normally until 3 years when she started toe walking and had frequent falls. By 4, her legs crossed with ambulation, consistent with spastic diplegia. Lower extremity spasticity progressed, and she lost independent ambulation at 9 years, when she also developed difficulty with handwriting. By 10, she developed dysarthric speech and a head and hand tremor. By 11, she developed scoliosis and head drop. When first seen at 13 years, she was nonambulatory and unable to write, with unintelligible speech and difficulty chewing. Receptive language, cognition and hearing appeared intact. She had no history of seizures. Brain magnetic resonance imaging (MRI) at 8 years demonstrated an atrophic cerebellum, slightly flat pons, mild thinning of the corpus callosum, prominent lateral ventricles, and bilateral posterior periventricular Fluid Attenuated Inversion Recovery (FLAIR) hyperintensities. There was no evidence of brain iron accumulation (Fig. 1c-f ). Patient 2 is her 5-year-old brother. He developed normally until 2 years, when a labored gait associated with scissoring and clumsiness was noted. By 3 years, he had lower extremity spasticity and slow speech. At 5 years, he had lost independent ambulation, had difficulty gripping a pencil, and developed a head drop and tremor. His decline seemed quicker than his sister's. Brain MRI at 5 years revealed a mildly atrophic cerebellum, normal pons and corpus callosum, and subtle T2 hyperintensities near the posterior horns of the lateral ventricles. There was no brain iron accumulation (Fig. 1g-j) . Table 1 shows clinical examination findings. Oligonucleotide-based microarray analysis (Affymetrix, Juan Capistrano, CA; 6.0, >1.8 million probes) revealed two large, contiguous genomic segments (16q21-q23.1, including FA2H , and 19q3.12-q13.33) with loss of heterozygosity. Direct sequencing of FA2H in the affected siblings identified a homozygous deletion (c.509_510 delAC) resulting in a frameshift and premature stop codon (p.Y170*). The parents and unaffected sister were heterozygous carriers. This mutation was previously reported in two brothers from Albania with NBIA (4), possibly representing a founder mutation from the Balkan region.
Review of the few published cases does not reveal a clear genotype-phenotype correlation, though putative null mutations or deletions causing the absence of FA2H may result in a more severe phenotype than missense mutations (1, 3, 7) . Within the spectrum of FAHN, MRI can be unremarkable or show leukodystrophy or subcortical and periventricular T2 white matter hyperintensities, atrophy of the cerebellum, brainstem or cervical spinal cord, thinning of the corpus callosum, or iron accumulation in the globus pallidus. A family with the same c.509_510 delAC mutation and NBIA has been reported (4). In contrast, the siblings presented here showed no brain iron deposition, indicating that this mutation may not always result in NBIA. Thus, additional factors may play a role in FAHN phenotypic expression. Imaging studies also indicate that FAHN represents a clinical spectrum rather than a distinct syndrome (5) . The significant supranuclear upgaze palsy seen here has only been reported in a Pakistani patient (1) and adds to oculomotor abnormalities (strabismus and ocular apraxia) reported in other FAHN patients. The clinical spectrum and pathogenic mechanisms of FAHN are still unfolding.
